Intellectual Property India Publishes Patent Application for 'Ligand-Drug Conjugate Of Exatecan Analogue, And Medical Use Thereof' Filed by Beigene Switzerland Gmbh

MUMBAI, India, May 16 -- Intellectual Property India has published a patent application (202517039183 A) filed by Beigene Switzerland Gmbh, Basel, Switzerland, on April 23, for 'ligand-drug conjugate of exatecan analogue, and medical use thereof.'

Inventor(s) include Tsai, Charng-Sheng; Tsai, Mei-Hsuan; Li, Bing; Xue, Liu; He, Maomao; Wang, Zewei; Luo, Wei; Qu, Yi; Yang, Xiaokun; and Wang, Ce.

The application for the patent was published on May 16, under issue no. 20/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are compounds having formulas (I) or (VII) or pharmaceutically acceptable salts, tautomers, isotopologues, stereoisomers, or prodrugs thereof; ligand-drug conjugates and pharmaceuti...